NovaScan Awarded $3.7 Million CPRIT Grant to Advance MarginScan™ for Breast Cancer Surgery
NovaScan, Inc., an AI-enhanced cancer detection and treatment company, today announced that it has been awarded a $3.7 million non-dilutive grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
Study Involving NovaScan’s Groundbreaking MarginScan™ Intraoperative Cancer Device Selected for Presentation at 2025 AAD Innovation Academy
NovaScan’s groundbreaking MarginScan™ device for real-time cancer detection during Mohs surgery has been selected for presentation at the 2025 AAD Innovation Academy’s “Future of Dermatology” session.
Clinical Results with NovaScan MarginScan™ Device to be Presented at Wisconsin Dermatology Society Meeting
NovaScan, a leader in point-of-care cancer detection and treatment technologies, is pleased to announce that its MarginScan™ device will be featured in a poster presentation at the Wisconsin Dermatology Society (WDS) Spring Meeting on April 26, 2025.
NovaScan Announces a New Pancreatic Trial at the University of Illinois Medical Center
Trial will focus on chronic pancreatitis patients December 3, 2024 Chicago, IL: NovaScan, a clinical stage oncology company based in Chicago, today announced that a new clinical trial has started employing the NovaScan Canary biopsy assessment device to detect...
NovaScan Announces the Appointment of Two Luminary Advisors
Robert W. Cook, Ph.D. and Robert Zieserl will become Advisors to the company Chicago IL – October 22, 2024: NovaScan, a clinical stage oncology company based in Chicago, IL, announced the appointment of two luminary advisors who will assist the company as it advances...
Epredia and NovaScan Announce Intent for U.S. Distribution Agreement for MarginScanTM Device for Non-Melanoma Skin Cancer Detection
Avantik to Serve as Primary Distribution Partner Portsmouth, NH – May 2, 2024 – Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for...
NovaScan and Dr Paul Grippo Receive Competitive Award for Pancreatic Cancer Research
February 7, 2024 Chicago, IL: NovaScan, a clinical stage oncology company based in Chicago, today announced that a collaboration with Dr Paul Grippo, Associate Professor of Gastroenterology and Hepatology at the University of Illinois College of Medicine, has been...
NovaScan Participating in Multiple Conferences in Lung and GI
September 26, 2023, Chicago, IL: NovaScan, Inc. a clinical stage venture-backed oncology company, announced today that the company has had multiple abstracts accepted in upcoming leading medical conferences around the globe. These conferences include the following:...